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A number of acute or repeated stimuli can induce expression of DeltaFosB (1FosB),
a transcription factor derived from the fosB gene (an osteosarcoma viral oncogene)
via alternative splicing. 1FosB protein is currently viewed as a ‘molecular switch’
to repeated stimuli that gradually converts acute responses into relatively stable
adaptations underlying long-term neural and behavioral plasticity. 1FosB has received
extensive attention in drug addition, depression, and stress adaptation, but changes in
1FosB protein expression during pain is not fully understood. In this study we explored
1FosB expression in the medial prefrontal cortex (mPFC) of rats experiencing chronic
or acute stress-induced pain. Our data reveal that chronic pain induced by neonatal
colorectal distension, chronic constriction injury (CCI) of the sciatic nerve, or maternal
separation was associated with an increase in 1fosB protein expression in mPFC, but
acute application of acetic acid or zymosan did not alter the 1FosB protein expression.
1FosB expression in the rat visual cortex, a non pain-related brain region, did not
change in response to (CCI) of the sciatic nerve and acetic acid treatment. In conclusion,
our results indicate that 1FosB protein expression is significantly elevated in rats that
have experienced chronic pain and stress, but not acute pain. The 1FosB protein
may serve as an important transcription factor for chronic stress-induced pain. Further
research is needed to improve the understanding of both the upstream signaling leading
to 1FosB protein expression as well as the regulation of 1FosB gene expression in
cortical neurons.
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INTRODUCTION
Pain is associated with an alteration in gene expression and neuronal plasticity (Baliki et al.,
2014) that can result in persistent structural and functional modifications (Woolf and Costigan,
1999; Ji et al., 2014). Transcription factors bridge the pathological events in the central nervous
system (CNS) with alterations in gene expression during the pathogenesis of pain (Woolf
and Costigan, 1999; Zhang et al., 2015). Transcription factors belonging to the Fos family
may be important candidates for pain modulation (Luis-Delgado et al., 2006). Encoded by c-
fos, fosB, fra-1, and fra-2 genes (Herdegen and Leah, 1998), Fos family proteins are induced
rapidly and transiently in specific brain regions to regulate downstream gene expression
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in response to environmental factors (Sheng and Greenberg,
1990; Perrotti et al., 2004). These Fos family proteins form
heterodimers with Jun family proteins (c-Jun, JunB, or JunD) to
form functioning activator protein-1 (AP1) transcription factors
that bind to AP1 consensus sites present in the promoters of
certain genes to regulate their transcription. The DeltaFosB
(1FosB) protein is a truncated splice variant of fosB, missing 101
amino acids at the C-terminal of the FosB protein (Nakabeppu
and Nathans, 1991). Recently the 1FosB protein has received
extensive attention in drug addition, depression and stress
adaptation (McClung and Nestler, 2003; Perrotti et al., 2004).
The 1FosB protein is encoded by the fosB gene and
shares homology with other Fos family proteins (Morgan
and Curran, 1995). 1FosB has the same dimerization and
DNA-binding activities of FosB. Upon stress stimulus, the
post-translational modifications of 1FosB protein lead to
different protein isoforms with half-lives between 10 h
and 8 days (McClung et al., 2004). Therefore, 1FosB
protein is assumed to function as a “molecular switch” that
mediates persistent adaptations in the brain’s response to
repetitive or long-lasting stimuli (Nestler et al., 1999, 2001).
In the CNS, 1FosB has been examined in the context of
electroconvulsive treatment and epilepsy (Morris et al.,
2000), addiction (McClung and Nestler, 2003; Zhang et al.,
2014), compulsive running (Werme et al., 2002), dyskinesia
(Andersson et al., 2003), and stress (Perrotti et al., 2004).
For instance, Zhang reported that 1FosB overexpression
decreases cocaine self-administration, enhances extinction of
cocaine seeking, and decreases cocaine-induced reinstatement
of intravenous cocaine self-administration (Zhang et al.,
2014). However, limited evidence suggests an involvement
of 1FosB protein in acute or chronic stress-induced pain
precipitation. Mice overexpressing the 1FosB protein in the
nucleus accumbens and the dorsal striatum displayed reduced
analgesic responses to acute morphine administration as well
as faster development of morphine tolerance (Zachariou et al.,
2006). Carrageenan-induced inflammation increases 1FosB
protein expression in the spinal cord (Luis-Delgado et al.,
2006). These reports suggest that 1FosB may be an important
molecular modulator participating in the pathogenesis of
pain. To date, the direct evidence of changes in 1FosB
protein expression in various pain models has not been
reported.
Pain is associated with depression and cognitive decline (Metz
et al., 2009; Zhang et al., 2015), suggesting an involvement of
cortical areas associated with cognitive functions. The medial
prefrontal cortex (mPFC) plays a critical role in pain-related
depression and anxiety, which are frequent co-morbidities of
chronic pain (Guida et al., 2015). Unilateral chronic constriction
injury (CCI) to the infraorbital nerve induces a strong, bilateral
upregulation of extracellular signal regulated kinases 1/2 (pERK-
1/2) in the ventral mPFC in rats (Devoize et al., 2011).
Stress induces 1FosB protein expression in mPFC, and that
overexpression of 1FosB in pre-limbic mPFC enhances stress
susceptibility in mice (Vialou et al., 2014). mPFC may be a key
brain region through which the 1FosB protein modulates the
establishment and maintenance of pain.
In the present study, we examined 1FosB protein expression
in mPFC in rodents that experienced acute and chronic stress-
induced pain. The visual cortex, a non pain-related brain region,
was used as a control. Our data reveal that chronic stress-induced
pain was associated with an increase in the expression of mPFC
1FosB protein, but1FosB expression did not change in rats that
experienced acute stress-induced pain. These results illuminate a
new molecular mechanism of pain, and may pave a new avenue
for development of therapeutics against pain.
MATERIALS AND METHODS
Animals
Male Sprague-Dawley rats weighing 220 to 250 g and C57B
mice weighing 21 to 24 g were obtained from the Experimental
Animal Center of Xuzhou Medical University (Xuzhou, China)
and housed in groups of four per standard polycarbonate cage
and kept on a standard 12 h light/dark cycle (lights on at
07:00 a.m.), constant temperature and humidity (22◦C and 50%,
respectively) with food provided ad libitum. All procedures were
conducted in accordance with the guidelines described in the
National Institutes of Health’s Guide for the Care and Use of
Laboratory Animals (NIH Publication No. 8023, revised 1978)
and the International Association for the Study of Pain, and
approved by the Institutional Animal Care and Use Committee
at Xuzhou Medical College.
Development of Pain Models
Development of Visceral Hypersensitivity Rat Model
with Colorectal Distensions
Visceral hypersensitivity was induced by adult colorectal
distension (CRD) in rats that experience neonatal CRDs as
described previously (Chen et al., 2015; Zhang et al., 2015). In
brief, neonatal CRDs were induced on postnatal days 8, 10, and 12
using an angioplasty balloon (length, 20.0 mm; diameter, 3.0 mm)
inserted into the upper rectum and descending colon (the section
of the large intestine that travels back down toward the rectum).
The balloon was distended with 0.3 ml water at a pressure of
60 mm Hg for 1 min before deflation and withdrawal. The
distention was repeated twice with a 30-min break. CRD for adult
rats was established 8 weeks later in which an 80 mm Hg (1 min)
distention was given twice with a 5 min interval. The extent of
visceral hypersensitivity was assessed with abdominal withdrawal
reflex (AWR) scores, pain threshold, and electromyography
activities of oblique muscles as described previously (Zhang et al.,
2015).
Chronic Constriction Injury (CCI) Neuropathic Pain
Model
The chronic neuropathic pain model was generated using a
chronic sciatic nerve compression injury method (Bennett and
Xie, 1988). Rats were anaesthetized with intraperitoneal injection
of 10% chloral hydrate at 400 mg/kg. After anaesthetization and
disinfection, the sciatic nerve trunk was isolated and ligated for
a total of four ligations at an interval of 1 mm. The sciatic nerve
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was exposed without ligation treatment in the control group. Paw
withdrawal latency (PWL) was used to evaluate the pain level.
Maternal Separation Model
The protocol of maternal separation was conducted as previously
described in detail (Wang et al., 2015). The male and female
rats were mated to produce litters. After birth, the pups were
randomly divided into two groups: the maternal separation group
and the non-maternal separation group. Neonatal mice were
separated from mothers for 4 h (10:00 a.m.–2:00 p.m.) per day
ranging from postnatal day 1 to day 15, and maintained on a
water-heating pad (29 ± 1◦C) separately from their littermates.
The pups in non-maternal separation group remained in their
home cages with their mothers and littermates during the 4 h
separation.
Acetic Acid-Elicited Acute Visceral Pain
Intraperitoneal acetic acid-induced abdominal contraction was
used to establish the acute pain model (Martinez et al., 1999). In
brief, mice were placed individually in a standard polycarbonate
cage, and allowed to habituate to the environment for 30 min.
Acetic acid (0.6% in distilled water) was injected intraperitoneally
in a volume of 10 ml/kg. Immediately after the acetic acid or
vehicle injection, pain responses were scored by counting the
number of abdominal contractions (writhing test) in 15 min
intervals for 1 h. An abdominal contraction was defined as a
lengthwise stretching of the torso with a concomitant arching of
the back.
Zymosan-Induced Paw Inflammatory Pain
Intraplantar injections of zymosan (1.25 mg/100 µl) were utilized
to induce paw inflammation. Sham group received an equal
volume of saline. The thermal latencies of the rats were measured
pre- and 0.5, 1, 2, 4, 8, and 24 h post-injection.
Immunofluorescence Labeling
Rats were deeply anesthetized with 10% chloral hydrate
(250 mg/kg) and perfused transcardially with 300 ml 0.9% saline,
followed by 4% paraformaldehyde. The entire brain was quickly
removed and further fixed in 4% paraformaldehyde for 48 h
at 4◦C before being equilibrated in a 30% sucrose solution at
4◦C for 2 days. Double immunofluorescence labeling was used
to identify 1FosB protein distribution in particular cell types.
The mPFC region was cut in 30-µm thick slices with a cryostat
(Leica CM1800; Heidelberg, Germany). Selected sections were
washed with PBS for 5 min three times, and then incubated with
10% donkey serum in PBS containing 0.3% Triton-X-100 for
2 h at room temperature before incubation with rabbit anti-delta
Fosb antibody (1:500, #9890, Cell Signaling Technology), anti-
neuronal nuclei (NeuN) antibody (1:200; MAB377X, Millipore),
anti-glial fibrillary acidic protein (GFAP; 1:200; #3670, Cell
Signaling Technology), or anti-ionized calcium-binding adaptor
molecule 1 (Iba-1; 1:200; ab5076, Abcam) at 4◦C for 24 h. Alexa
488 donkey anti-rabbit IgG (1:200), Alexa 594 donkey anti-
mouse IgG (1:200), or Alexa 594 donkey anti-goat IgG (1:200)
were added to the corresponding sections and incubated for 2 h
at room temperature. Tissue sections were mounted with 50%
glycerol mounting medium. Layer V of the prelimbic cortex
on the left hemisphere in each mouse was visualized with a
confocal laser microscope (FV1000; Olympus, Tokyo, Japan).
Tissue images were processed using Image Pro-Plus 5.0 software
(Media Cybernetics, Silver Spring, MD).
Western Blotting Analysis
The bilateral mPFC and visual cortex were collected from
fresh brain and lysed in RIPA lysis buffer containing 50 mM
Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% SDS, 1 mM sodium orthovanadate, and
1 mM Phenylmethanesulfonyl fluoride (PMSF). Homogenates
were keep on ice for another 30 min before being centrifuged
at 8,000 g for 5 min at 4◦C; the supernatant containing
the cytoplasmic components was saved at −80◦C before
analysis. Equal amounts of protein (80 µg) were separated
by SDS-PAGE, transferred electrophoretically to nitrocellulose
membrane, and incubated with rabbit polyclonal anti-1FosB
overnight at 4◦C. The membrane was washed thoroughly and
incubated with AP-conjugated secondary antibody (1:1000) for
2 h at room temperature. Protein bands were visualized using
the BCIP/NBT Alkaline Phosphatase Color Development Kit
and quantified using Image J software (National Institutes of
Health).
Statistical Analysis
Data were expressed as mean ± SEM. The time-course of the
number of abdominal contraction was analyzed by a two-way
repeated measures ANOVA. Student’s t-test, one-way ANOVA,
and two-way ANOVA were also used. If significance was found,
post hoc Bonferroni multiple comparison was used. All statistical
tests were conducted using SPSS 19.0 software package (IBM,
Armonk, NY, USA) with p < 0.05 considered statistically
significant.
RESULTS
Neonatal CRD Exposure is Associated
with an Increase in Adult 1FosB Protein
Expression in mPFC
The 1FosB protein labeling was compared with neuronal
marker NeuN, microglial marker Iba-1 and astrocyte marker
GFAP. The top row in Figure 1A shows the 1FosB and
NeuN staining in prelimbic area of drug-naïve rats. Rows
2–4 in Figure 1A illustrate protein staining in rats that had
experienced neonatal and adult CRDs. As compared to drug-
naïve rats, the rats experienced CRDs presented a significant
increase in NeuN and 1FosB immunoreactivity. 1FosB was
visualized in pyramidal neurons marked by NeuN staining
(Figure 1A). A two-way ANOVA on body weight revealed
a significant main effect of neonatal CRDs [F(1,8) = 218.56,
p < 0.01], a significant main effect of adult CRD [F(1,8) = 8.80,
p < 0.05], but not the neonatal × adult CRDs interaction
[F(1,8) = 6.39, p = 0.035] (n = 8 in each group; Figure 1B).
As compared to naïve rats, there was a significant increase in
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FIGURE 1 | Neonatal colorectal distension (CRD) exposure is associated with an increase in adult 1FosB expression in mFPC. 1FosB protein labeling
was compared with neuronal marker NeuN, microglial marker Iba-1 and astrocyte marker GFAP. 1FosB was visualized in pyramidal neurons marked by NeuN
staining. Row one came from drug-naïve rats, and rows 2 to 4 was from rats that experienced neonatal and adult CRDs. Scale bar = 100 µm (A). Mice received
neonatal and/or adult colorectal distension. There was no difference in body weight. (B; n = 8 per group). A two-way ANOVA on 1FosB expression revealed a
significant main effect of neonatal CRDs (p < 0.01) and a significant main effect of adult CRDs (p < 0.05). Rats that experienced neonatal or a combination of
neonatal and adult CRDs presented a significant increase in 1FosB expression compared with rats without CRDs or adult CRD only (C). Data were expressed as
mean ± SEM, n = 3 in each group. **p < 0.01.
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1FosB protein expression in rats that had experienced neonatal
CRDs [t(4) = 11.46, p < 0.01], adult CRDs [t(4) = 4.98,
p < 0.01] or a combination of neonatal and adult CRDs
[t(4)= 11.78, p< 0.01]. Adult CRD rats presented a significantly
lower expression of 1FosB protein levels as compared with
rats that had experienced neonatal CRDs [t(4) = 8.99,
p < 0.01] or a combination of neonatal and adult CRDs
[t(4) = 0.9.35, p < 0.01]. There was no difference between
rats that had experienced neonatal CRDs and those with a
combination of neonatal + adult CRDs [t(4) = 0.26, p = 0.81]
(Figure 1C).
Chronic Constriction Injury Is Associated
with an Increase in Adult 1FosB Protein
Expression in mPFC
The CCI in rats altered the PWL score (Figure 2A). A one-
way ANOVA showed a significant difference [F(2,48) = 61.51,
p < 0.01]; Post hoc Bonferroni’s multiple comparisons showed
that CCI rats (n = 17) presented a significant decrease in PWL
as compared to control (n = 17; p < 0.01) or sham rats (n = 17;
p < 0.01). There was no difference between control and sham
rats. The CCI in rats altered the 1FosB protein expression
(Figure 2B). A one-way ANOVA showed a significant difference
[F(2,9) = 174.7, p < 0.01]; Post hoc Bonferroni’s multiple
comparisons CCI rats (n = 4) presented a significant increase in
1FosB expression as compared to control (n = 4; p < 0.01) and
sham rats (n = 4; p < 0.01). Sham rats presented a significant
increase in 1FosB protein expression as compared to control
rats (p < 0.01). On the other hand, 1FosB protein expression in
the visual cortex was not statistically different between control,
sham and CCI rats [F(2,6) = 0.02, p = 0.98; n = 3 per group;
Figure 2C].
Maternal Separation Is Associated with
an Increase in Adult 1FosB Expression
in mPFC
Rats that underwent maternal separation presented a significant
increase in 1FosB protein expression in mPFC compared with
that in the control group [t(4) = 4.95, p < 0.01, n = 3 per group;
Figure 3].
Acetic Acid-Induced Acute Visceral Pain
Does Not Affect 1FosB Expression in
mPFC
Intraperitoneal injection of 0.6% acetic acid increased the number
of abdominal contractions compared with that in the control
group (Figure 4A). A two-way repeated measures ANOVA
revealed a significant main effect of treatment [F(1,18) = 599.51,
p < 0.01], a significant main effect of time [F(3,54) = 123.39,
p < 0.01], and a significant time × treatment interaction
[F(3,54) = 123.39, p < 0.01, n = 10 per group]. There was
no significant difference in 1FosB expression in mPFC between
acetic acid group and control group [F(4,19) = 0.32, p = 0.86,
n= 3; Figure 4B]. The1FosB expression in the visual cortex was
not found to be statistically different between vehicle and acetic
acid-treated rats [t(4)= 0.14, p= 0.89; n= 3; Figure 4C].
Zymosan-Induced Paw Inflammatory
Pain Does Not Affect 1FosB Expression
in mPFC
Intrapaw injection of zymosan decreased the latency of paw
withdrawal compared with that in control group (Figure 5A).
A two-way repeated measures ANOVA revealed a significant
main effect of treatment [F(1,10)= 157.97, p< 0.01], a significant
FIGURE 2 | Chronic constriction injury (CCI) is associated with an increase in adult 1FosB expression in mPFC. Rats that received CCI of the sciatic
nerve presented a significant decrease in paw withdrawal latency (PWL; A; n = 17 per group) and a significant increase in 1FosB expression. (B; n = 4 per group)
compared with control or sham rats. There was no change in 1FosB expression in the visual cortex between control, sham and CCI groups. (C; n = 3 per group).
Data were expressed as mean ± SEM, ∗∗p < 0.01.
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FIGURE 3 | Maternal separation is associated with an increase in adult
1FosB expression in mPFC. Rats exposed to maternal separation
exhibited a significant increase in 1FosB expression in mPFC compared with
that in the control group (p < 0.01, n = 3). Data were expressed as
mean ± SEM, ∗∗p < 0.01 vs. control.
main effect of time [F(6,60) = 37.60, p < 0.01], and significant
time × treatment interaction [F(6,60) = 27.84, p < 0.01,
n = 6 per group]. There was no significant difference in 1FosB
expression in mPFC between zymosan-group and control group
[F(6,14)= 0.97, p= 0.48, n= 3; Figure 5B].
DISCUSSION
In this study, we examined 1FosB protein expression in
animals that experienced acute or chronic stress-induced pain.
Our data reveal an increase in 1FosB expression in animals
with chronic pain induced by CRD, CCI, and maternal
separation, but not in acetic acid-induced acute visceral
pain and zymosan-induced acute inflammatory pain. 1FosB
protein expression in the visual cortex did not change as
a result of CCI or acetic acid-induced pain. These results
suggest that 1FosB may be an important transcriptional
factor that modulates neuronal adaptation specifically to
chronic stress-induced pain. Elucidation of the molecular
mechanisms that are responsible for the specific1FosB response
to chronic pain provides new opportunities for therapeutic
approaches to prevent acute pain translated into chronic
pain.
Our data indicate that 1FosB protein expression is increased
in rats that experienced neonatal CRDs. Visceral hypersensitivity
is a major contributor to irritable bowel syndrome and other
disorders with chronic visceral pain (Chey et al., 2015). The
pathogenesis of visceral hypersensitivity remains speculative due
to undetectable structural abnormalities in the peripheral organs
(Chen et al., 2015). In the present study, visceral hypersensitivity
was developed by neonatal and adult CRDs in rats. We did not
find any identifiable behavioral abnormalities in adult rats that
experienced neonatal CRDs (Chen et al., 2015; Zhang et al.,
2015), but adult re-exposure to CRD precipitated behavioral
abnormalities and visceral pain hypersensitivity only in rats
that experienced neonatal CRDs (Zhang et al., 2015). These
results suggest that neonatal CRDs alter the neuronal traits,
in spite of the body maintaining a normal phenotype through
adaptation. Such a quiescent event can be prompted by a
subthreshold stressor imposed late in life, and induces changes
in genotype and phenotype, such as fear reaction, cognition,
dysthymia, novelty-seeking, and pain perception (Charmandari
et al., 2003). Our data indicate that the neonatal CRD is associated
with a significant increase in 1FosB protein expression in
mPFC.
Chronic neuropathic pain is a prevalent and debilitating
condition, affecting 7–18% of the population (Bouhassira
et al., 2008; Toth et al., 2009). Clinical manifestation includes
spontaneous pain, dysaesthesia, paraesthesia, allodynia, and
hyperalgesia. The sensory symptoms are co-morbid with mental
impairments, such as insomnia and depression. CCI of the sciatic
nerve is a chronic neuropathic pain resulting from damage to
the peripheral nervous system. The CCI model is a popular
tool to study mechanisms for chronic neuropathic pain and to
identify experimental compounds with analgesic properties that
are palliative for chronic neuropathic pain. Unilateral CCI to
the infraorbital nerve induces a strong, bilateral upregulation of
pERK-1/2 in the ventral mPFC of rats (Devoize et al., 2011). Our
data reveal an increase in the expression of 1FosB in mPFC
in rats that experienced CCI. Interestingly, CCI did not alter
1FosB expression in the visual cortex, a non pain-related brain
region.
Early life adversity, such as postnatal maternal separation,
plays a central role in the development of psychopathologies
during individual ontogeny. The adverse early life event is
a risk factor for the development of psychiatric diseases in
adult. In rats, maternal separation, which deprives pups of
their mothers, has often been used as a model for early
life adversity (Hall, 1998). Maternal separation has been
demonstrated to induce behavioral and cognitive abnormalities,
such as increased depressive and anxiety-like behaviors (Rentesi
et al., 2010) and prepulse inhibition and learning deficits
(Garner et al., 2007). Maternal separation has also been shown
to decrease new born cells in the hippocampus and the
granular cell in the dentate gyrus of juvenile and adult rats
(Hulshof et al., 2011), and decrease the expression of brain-
derived neurotrophic factor (BDNF) in the mPFC in young
adult rats (Wang et al., 2015). These findings suggest that
maternal separation can affect the neuroplasticity of rats. In
line with these results, our data revealed an increase in the
expression of 1FosB in mPFC in rats that experienced maternal
separation.
Local or intraperitoneal injection of zymosan, a
polysaccharide component of the cell wall from Saccharomyces
cerevisiae, or acetic acid, represents a self-resolving model of
acute inflammation and pain, which has been widely used for the
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FIGURE 4 | Acetic acid-induced acute pain does not affect 1FosB expression in mPFC. Intraperitoneal injection of 0.6% acetic acid increased the number of
abdominal contractions compared with that in control group. (A; n = 10 per group). The 1FosB expression in mPFC was not significantly altered 15, 30, 45, and
60 min after acetic acid application. (B; n = 3 per group). There was no change in 1FosB expression in the visual cortex between control and acetic acid-treated
groups. (C; n = 3 per group; brain tissues were collected at 45 min after acetic acid treatment). Data were expressed as mean ± SEM, ∗∗p < 0.01 vs. vehicle.
FIGURE 5 | Zymosan-induced paw inflammatory pain does not affect 1FosB expression in mPFC. Intrapaw injection of zymosan decreased the latency of
paw withdrawal compared to that in the control group. (A; n = 6 per group). The 1FosB expression in mPFC was not significantly altered 1, 3, 6, 8, 12, and 24 h
after zymosan application. (B; n = 3 per group). Data were expressed as mean ± SEM, ∗∗p < 0.01 vs. saline.
quantification of particular cell types and inflammation-related
soluble factors (Cash et al., 2009). Intraplantar administration of
zymosan in the rat hindpaw produces a reliable and quantifiable
thermal and mechanical hyperalgesia accompanied by oedema
that closely mimics the symptoms of inflammation in humans
(Meller and Gebhart, 1997). Our data indicate that the expression
of 1FosB in mPFC is not altered in rats with acetic acid- or
zymosan- induced acute pain. Since 1FosB expression is altered
only in chronic or persistent exposure to chronic stimuli, it
is not surprising that we did not observe the 1FosB change
in either the acetic acid- or the zymosan-induced acute pain
models.
Early life stress, such as neonatal CRD and maternal
separation, is a potential contributor to visceral hypersensitivity
and pain (Al-Chaer et al., 2000; Zhou et al., 2010). The
developing brain undergoes rapid growth and is characterized
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by high turnover of neuronal wiring. Early life stress affects
the developmental trajectory of the neurocircuitry in the CNS
and alters vulnerability to subsequent stress during adulthood
(Wouters et al., 2012). Early life stress may produce stable
changes in neuronal plasticity, function, and communication,
and increase susceptibility to developing the enhanced pain-
like behavioral profiles and later-life psychopathology (Van den
Bergh et al., 2008; Green et al., 2011; Amath et al., 2012).
The 1FosB protein is elevated in chronic, but not acute
stress-induced pain models. It is posited that 1FosB functions
as a molecular switch that mediates persistent adaptations
in the brain response to chronic pain (Luis-Delgado et al.,
2006).
The 1FosB protein is a unique transcription factor that
plays an essential role in long-term adaptive changes in the
brain associated with diverse conditions, such as drug addiction,
Parkinson’s disease, depression, and antidepressant treatment.
In CNS, 1FosB expression is regulated in a regional- and cell-
type-specific manner by many types of chronic perturbations
(Nestler et al., 2001; Werme et al., 2002). Once induced,
it persists for a long period of time due to its unusual
stability. The transcriptional effects of 1FosB are complex,
because the protein can function as both a transcriptional
activator and repressor. Progress has been made in identifying
specific target genes for 1FosB and in relating some of these
genes to the cellular and behavioral actions of the 1fosB
protein. Future studies will help us to better understand
the biochemical basis of the 1fosB protein’s unique stability,
as well as the precise molecular pathways through which
this transcription factor produces its complex effects on
neuronal plasticity and complex behavior (McClung et al.,
2004).
The upstream and downstream signaling pathways of
1FosB remain largely unknown. Different stimuli can
invoke different molecular mechanisms to induce 1fosB
protein levels. Inflammation is a major contributor to
pain. This inflammatory neuroplasticity is the consequence
of a combination of activity-dependent changes in the
neurons and specific signal molecules initiating particular
signal-transduction pathways and altering gene expression
(Woolf and Costigan, 1999). We recently demonstrated that
activation of microglial toll-like receptor 4 (TLR4)/ myeloid
differentiation factor 88 (MyD88)/ nuclear factor κB (NF-
κB) signaling, as well as proinflammatory cytokines tumor
necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) facilitated
the development of visceral hypersensitivity and pain (Chen
et al., 2015; Zhang et al., 2015). The casual relation between
inflammatory modulators and the 1FosB protein needs further
exploration.
The downstream of 1FosB remains elusive. 1FosB dimerizes
predominantly with JunD to form a heterodimerized AP1
complex (Hiroi et al., 1998). Recent in vitro evidence has
indicated that 1FosB can also form homodimers (Jorissen
et al., 2007). 1FosB acts as either a transcriptional repressor
or activator (McClung and Nestler, 2003). A plethora of
factors participate in hyperalgesia and allodynia following
peripheral tissue inflammation, including cyclin-dependent
kinase 5 (CDK5; Chen et al., 2000), cholecystokinin (CCK)-
B receptor, (Covington et al., 2010) NMDA receptor subunit
1 (NR1; Hiroi et al., 1998) and AMPA ionotropic glutamate
receptor subunit 2 (GluR2; Kelz et al., 1999; Rygh et al., 2001).
Such data from the literature suggest that the above target genes
could be candidates of interest for future studies to understand
the action of the1FosB protein in the CNS.
The chronic conditions tested here do not allow separation
of pain processing in the mPFC due to stress, depression
or anxiety. 1FosB is a transcriptional regulator of stress
(Nestler, 2015). Stress, e.g., pain, physical abuse, neonatal
maternal separation, or exposure to an immune challenge can
induce genetic, physiological and behavioral changes (Mayer
and Collins, 2002). The 1FosB protein accumulates within
the same brain regions after repeated stress exposure, whereas
other Fos family members show desensitization [i.e., reduced
induction compared with initial drug exposures (Perrotti et al.,
2004; Lehmann and Herkenham, 2011)]. Such accumulation
of 1FosB has been observed due to several forms of active
stress, such as chronic restraint stress, chronic unpredictable
stress, and chronic social defeat stress, whereas chronic social
isolation decreases 1FosB levels in nucleus accumbens (Vialou
et al., 2010). Stress induces 1FosB expression in mPFC, and
that overexpression of 1FosB in pre-limbic mPFC enhances
stress susceptibility in mice (Vialou et al., 2014). The mPFC
shows lower basal levels of 1FosB immunoreactivity, but
almost a threefold induction after chronic restraint stress in
rats (Perrotti et al., 2004). We found rats that experienced
neonatal CRD and maternal separation showed an elevation in
the 1fosB protein levels. Maladaptation of the stress system
may impair neuronal development, and account for a number
of endocrine, metabolic, autoimmune, and psychiatric disorders
(Green et al., 2011; Amath et al., 2012). Antidepressants
can reverse this social withdrawal syndrome by boosting
1FosB. Moreover, 1FosB is conspicuously depleted in brains
of people who suffered from depression. Thus, induction of
1FosB is a positive adaptation for coping with stress. Under
most circumstances, stress, depression, anxiety and pain share
common contributors and neurobiological inhibitors. In this
study, we reported that chronic pain rat models presented
an elevation of 1FosB protein level in mFPC. Interestingly,
the 1FosB expression in the visual cortex, a non pain-related
region of the brain did not change due to CCI or acetic
acid treatments, suggesting that 1FosB expression to stress
and pain presents a regional specificity. The casual relationship
between chronic pain and the 1FosB protein need further
exploration.
A number of immunostaining studies show that 1FosB
expresses predominately in projection neurons (Perrotti
et al., 2004; Lobo et al., 2013; Nomaru et al., 2014). In the
prefrontal cortex, 1FosB exists in several layers of the cortex,
in particular in layers II/III and V. The 1FosB staining
was again localized in the neurons, with no colocalization
with GFAP, an astroglial marker seen primarily within
cortical pyramidal neurons; over 90% of the 1FosB+ cells
colabeled with vesicular glutamate transporter 1 (vGluT1; a
marker of glutamatergic neurons), with little colabeling seen
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with markers for various GABAergic interneurons (i.e., calbindin,
parvalbumin, or calretinin; Perrotti et al., 2004). Based on these
data, we predict that chronic stress elevates the 1FosB protein
expression in pyramidal neurons in mPFC.
CONCLUSION
Our results clearly show the expression of 1FosB was
significantly elevated in rats undergoing chronic, but not acute,
stress-induced pain. The 1FosB protein expression profile to
different stimuli supports the role of1FosB in neuronal plasticity
and suggests that it could be a useful molecular marker of
sustained pain. Further research is needed to improve our
understanding of both the upstream mechanism leading to
1FosB protein production and the downstream mechanism by
which the1FosB protein might participate in plasticity.
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